ID
45165
Beschreibung
Principal Investigator: Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA MeSH: Diabetic Nephropathies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000302 A collection of patients with type-2 diabetes was collected at the Joslin Diabetes Center. Patients were categorized to a group of cases with diabetic nephropathy, and a group of controls with normoalbuminuria. From these groups, 173 cases and 177 controls were randomly selected for a genome-wide association study.
Link
Stichworte
Versionen (2)
- 25.08.22 25.08.22 - Chiara Middel
- 12.10.22 12.10.22 - Adrian Schulz
Rechteinhaber
Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA
Hochgeladen am
12. Oktober 2022
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000302 Genetic Study on Nephropathy in Type-2 Diabetes
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
C2700446 (UMLS CUI [1,2])
C1828181 (UMLS CUI [2,1])
C1298908 (UMLS CUI [2,2])
C0745343 (UMLS CUI [2,3])
C1828181 (UMLS CUI [3,1])
C0205087 (UMLS CUI [3,2])
C1704686 (UMLS CUI [3,3])
C0745343 (UMLS CUI [3,4])
C0022658 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,2])
C0205307 (UMLS CUI [1,2])
C2316786 (UMLS CUI [1,2])
C0011849 (UMLS CUI [1,2])
C1698493 (UMLS CUI [1,2])
C0854078 (UMLS CUI [2,1])
C0730345 (UMLS CUI [3,1])
C2317473 (UMLS CUI [4,1])
C2316810 (UMLS CUI [4,2])